Human Anti-SIRPA Recombinant Antibody (clone 29-AM3-4); Fab Fragment

CAT#: HPAB-0024-LSX-F(E)

Recombinant monoclonal antibody (clone 29-AM3-4) Fab fragment binds to SIRPαV1 and V2. Clone 29-AM4-4 is a humanized antibody that can be potentially used in the treatment studies of Acute myeloid leukemia (AML).

Gene Expression
Figure 1 Cerebral cortex Figure 2 Colon Figure 3 Lymph node Figure 4 RNA cell line category: Cell line enhanced (fHDF/TERT166, RPTEC TERT1, SK-MEL-30)

Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized Fab
  • Specificity
  • Human SIRPα
  • Species Reactivity
  • Human, Mouse
  • Clone
  • 29-AM3-4
  • Applications
  • ELISA
  • Related Disease
  • Acute myeloid leukemia

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • SIRPA; signal-regulatory protein alpha; BIT; MFR; P84; SIRP; MYD-1; SHPS1; CD172A; PTPNS1; tyrosine-protein phosphatase non-receptor type substrate 1; myd-1 antigen; inhibitory receptor SHPS-1; macrophage fusion receptor; CD172 antigen-like family member A; tyrosine phosphatase SHP substrate 1; brain-immunoglobulin-like molecule with tyrosine-based activation motifs
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for HPAB-0024-LSX-F(E). Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Excellent Specificity
We've employed this Fab Fragment in multiple assays - its specificity in targeting SIRPA has enhanced our detection capabilities considerably. The consistent performance across different experimental conditions has been reassuring, providing us with reliable results and confidence in our ongoing immune response studies.
Breast cancer biomarkers at key points during disease progression
Invaluable for Leukemia Research
The Anti-SIRPA Fab Fragment has significantly advanced our research in acute myeloid leukemia. Its ability to block SIRPα effectively revealed crucial insights into immune evasion mechanisms used by leukemia cells. The precise blocking capacity strengthens our therapeutic strategies, making it a cornerstone of promising AML treatments.
Breast cancer biomarkers at key points during disease progression
Crucial for Immune Checkpoint Blockade Studies
We've found this Fab Fragment extremely useful in examining immune checkpoint interactions. Its clear, targeted interference with the CD47-SIRPα pathway enables us to map out immune cell responses, essential for developing checkpoint inhibitors. Its reliability across repeated experiments adds immense value to our project outcomes.

Q&As

  1. What is the primary application of the Anti-SIRPA Fab Fragment in research?

    A: The Anti-SIRPA Fab Fragment (clone 29-AM3-4) is primarily used in ELISA to study the interaction between CD47 and SIRPα, which is a key focus in cancer immunotherapy research. This fragment format allows researchers to investigate the underlying mechanisms of immune evasion by tumors, facilitating the development of potential therapeutic strategies.

  2. How does the Fab Fragment format benefit studies involving SIRPA?

    A: The Fab Fragment format enhances tissue penetration due to its smaller size compared to full-length antibodies, making it highly suitable for in vivo studies and imaging applications. Its ability to precisely target and block specific sites on SIRPα enables detailed examination of immune checkpoint roles in diseases, thereby aiding in therapeutic research and development.

  3. How does the Anti-SIRPA Fab Fragment contribute to the study of acute myeloid leukemia (AML)?

    A: The Anti-SIRPA Fab Fragment is pivotal in research on AML due to its ability to block the CD47-SIRPα pathway, often utilized by cancer cells to evade immune clearance. By interrupting this pathway, the Fab fragment facilitates the exploration of potential therapies that activate macrophage-mediated phagocytosis of leukemia cells, providing insights into novel treatment options for AML.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Clone 29-AM3-4"

See other products for "Sirpa"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NAB-1201-VHH Recombinant Anti-Mouse Sirpa VHH Single Domain Antibody IP, FC, ChiP, Neut Llama VHH
CAT Product Name Application Type
BRD-0465MZ Chicken Anti-PTPNS1 Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
NEUT-1970CQ Recombinant Rat Anti-Sirpa Antibody (P84) FC, BL, IF, IHC, IP IgG1, κ
CAT Product Name Application Type
NEUT-1971CQ Recombinant Mouse Anti-Sirpa Antibody (CBL650) WB, FC, CyTOF, Neut IgG2b
CAT Product Name Application Type
VS-0724-YC1462 AbPlus™ Anti-SIRPA Magnetic Beads (VS-0724-YC1462) IP, Protein Purification
CAT Product Name Application Type
VS-0325-FY86 Human Anti-SIRPA (clone 29-AM3-35) scFv-Fc Chimera ELISA, Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC143 Recombinant Anti-SIRPA Vesicular Antibody, EV Displayed (VS-0425-YC143) Cyt, ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare